Business Description
Austar Lifesciences Ltd
ISIN : KYG0632L1023
Share Class Description:
HKSE:06118: Shs Reg SCompare
Compare
Traded in other countries / regions
06118.Hong KongAULSF.USA IPO Date
2014-11-07Description
Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess Systems; Clean Room and Automation Control and Monitoring Systems; Powder and Solid Systems; Good Manufacturing Practice (GMP) Compliance Services; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.31 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | -158.41 | |||||
| Interest Coverage | 0.93 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.39 | |||||
| Beneish M-Score | -2.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.9 | |||||
| 3-Year EBITDA Growth Rate | -32.6 | |||||
| 3-Year FCF Growth Rate | -101.2 | |||||
| 3-Year Book Growth Rate | 11.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.57 | |||||
| 9-Day RSI | 45.02 | |||||
| 14-Day RSI | 45.13 | |||||
| 6-1 Month Momentum % | -17.5 | |||||
| 12-1 Month Momentum % | -66.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.32 | |||||
| Quick Ratio | 1.1 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 80.34 | |||||
| Days Sales Outstanding | 88.09 | |||||
| Days Payable | 120.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -27.74 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 19.05 | |||||
| Operating Margin % | 0.98 | |||||
| Net Margin % | -4.42 | |||||
| FCF Margin % | -1.34 | |||||
| ROE % | -8.47 | |||||
| ROA % | -3.1 | |||||
| ROIC % | 1.24 | |||||
| ROC (Joel Greenblatt) % | -0.76 | |||||
| ROCE % | -0.29 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 6.89 | |||||
| PS Ratio | 0.18 | |||||
| PB Ratio | 0.38 | |||||
| Price-to-Tangible-Book | 0.44 | |||||
| Price-to-Operating-Cash-Flow | 13.5 | |||||
| EV-to-EBIT | -210.64 | |||||
| EV-to-EBITDA | -210.64 | |||||
| EV-to-Revenue | 0.39 | |||||
| EV-to-FCF | -29.95 | |||||
| Price-to-Net-Current-Asset-Value | 1.44 | |||||
| Earnings Yield (Greenblatt) % | -0.47 | |||||
| FCF Yield % | -7.1 | |||||
| Forward Rate of Return (Yacktman) % | -16.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Austar Lifesciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,678.022 | ||
| EPS (TTM) (HK$) | -0.142 | ||
| Beta | 0.89 | ||
| Volatility % | 58.47 | ||
| 14-Day RSI | 45.13 | ||
| 14-Day ATR (HK$) | 0.039307 | ||
| 20-Day SMA (HK$) | 0.6275 | ||
| 12-1 Month Momentum % | -66.15 | ||
| 52-Week Range (HK$) | 0.47 - 2.2 | ||
| Shares Outstanding (Mil) | 512.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Austar Lifesciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Austar Lifesciences Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Austar Lifesciences Ltd Frequently Asked Questions
What is Austar Lifesciences Ltd(HKSE:06118)'s stock price today?
The current price of HKSE:06118 is HK$0.62. The 52 week high of HKSE:06118 is HK$2.20 and 52 week low is HK$0.47.
When is next earnings date of Austar Lifesciences Ltd(HKSE:06118)?
The next earnings date of Austar Lifesciences Ltd(HKSE:06118) is .
Does Austar Lifesciences Ltd(HKSE:06118) pay dividends? If so, how much?
Austar Lifesciences Ltd(HKSE:06118) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers